BDH Industries Ltd. Stock Analysis 524828.BO

BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. The firm is also involved in the manufacturing of therapeutic formulations covering a range of pharmaceuticals. Its segments include Pharmaceuticals, and Renewable Energy. The firm is also engaged in the operations of renewable energy, by way of two wind turbines having capacity of 0.8 megawatts (MW) each located at Jaisalmer, Rajasthan. Its products include Analgesics, Antacids, Antibacterial, Anticoagulants, Anticonvulsants, Antifungals, Antihelmentinics, Antiasthmatic, Antimalarials, Antipsychotics and others. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow-Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, and others.